Recent studies indicate that popular weight-loss drugs, such as Ozempic and Wegovy, might play a role in treating or preventing certain cancers. This finding adds to the list of unexpected benefits linked to GLP-1s. Currently, one in eight American adults uses these medications.
William Brangham provides more details on this development. Brangham is a recognized correspondent and producer for PBS News Hour and also hosts Horizons from PBS.
Cancer Death Rates Decline in the U.S., But Disparities Remain 
COVID-19 Vaccine Study Highlights Effectiveness Amid Controversy 
Life Inside Biocontainment and Updates on Covid-19 Vaccine Policies 
Extreme Heat Risk Spreads Across the U.S. 
Efforts to Address Hospice Fraud and Strengthen Program Integrity 
CDC-Collected COVID-19 Vaccine Study Published Amid Methodological Debate